Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Cellular Immunotherapy for Oncology 1 by GenoImmune Therapeutics Biotechnology for Lung Cancer: Likelihood of Approval
Cellular Immunotherapy for Oncology 1 is under clinical development by GenoImmune Therapeutics Biotechnology and currently in Phase I for Lung...
Cellular Immunotherapy for Oncology 1 by GenoImmune Therapeutics Biotechnology for Metastatic Melanoma: Likelihood of Approval
Cellular Immunotherapy for Oncology 1 is under clinical development by GenoImmune Therapeutics Biotechnology and currently in Phase I for Metastatic...
Cellular Immunotherapy for Oncology 1 by GenoImmune Therapeutics Biotechnology for Gastric Cancer: Likelihood of Approval
Cellular Immunotherapy for Oncology 1 is under clinical development by GenoImmune Therapeutics Biotechnology and currently in Phase I for Gastric...